Kåre Schultz
2021
In 2021, Kåre Schultz earned a total compensation of $14.7M as President and Chief Executive Officer at Teva Pharmaceutical Industries, a 7% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $2,029,440 |
|---|---|
| Salary | $2,000,000 |
| Stock Awards | $9,999,994 |
| Other | $652,338 |
| Total | $14,681,772 |
Schultz received $10M in stock awards, accounting for 68% of the total pay in 2021.
Schultz also received $2M in non-equity incentive plan, $2M in salary and $652.3K in other compensation.
Rankings
In 2021, Kåre Schultz's compensation ranked 566th out of 12,415 executives tracked by ExecPay. In other words, Schultz earned more than 95.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 566 out of 12,415 | 95th |
Division Manufacturing | 188 out of 5,505 | 97th |
Major group Chemicals And Allied Products | 60 out of 2,375 | 98th |
Industry group Drugs | 54 out of 2,096 | 97th |
Industry Pharmaceutical Preparations | 32 out of 1,546 | 98th |
Source: SEC filing on April 13, 2022.
Schultz's colleagues
We found four more compensation records of executives who worked with Kåre Schultz at Teva Pharmaceutical Industries in 2021.
2021
Sven Dethlefs
Teva Pharmaceutical Industries
Executive Vice President, North America Commercial
2021
Eric Drap
Teva Pharmaceutical Industries
Executive Vice President, Global Operations
2021
Mark Sabag
Teva Pharmaceutical Industries
Executive Vice President, International Markets Commercial
2021
Eli Kalif
Teva Pharmaceutical Industries
Chief Financial Officer
News
Teva Pharmaceutical Industries CEO Kåre Schultz's 2021 pay slips 7% to $15M
April 13, 2022
Teva Pharmaceutical Industries CEO Kåre Schultz's 2020 pay jumps 36% to $16M
April 21, 2021
Teva Pharmaceutical Industries CEO Kåre Schultz's 2019 pay falls 64% to $12M
April 22, 2020
Teva Pharmaceutical Industries CEO Kåre Schultz's 2018 pay jumps 91% to $32M
April 16, 2019